Lombard Odier Asset Management (Europe)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-42,737
Closed -$17.4M – 282
2022
Q4
$17.4M Buy
42,737
+7,687
+22% +$2.98M 0.71% 45
2022
Q3
$11.4M Buy
35,050
+18,586
+113% +$6.83M 0.59% 52
2022
Q2
$5.77M Buy
+16,464
New +$6.71M 0.29% 101
2020
Q4
– Sell
-884
Closed -$348K – 295
2020
Q3
$348K Buy
+884
New +$327K 0.02% 226
2020
Q2
– Sell
-884
Closed -$214K – 221
2020
Q1
$214K Hold
884
– – 0.02% 266
2019
Q4
$231K Hold
884
– – 0.02% 363
2019
Q3
$240K Hold
884
– – 0.02% 338
2019
Q2
$243K Buy
+884
New +$218K 0.02% 338
2018
Q4
– Sell
-884
Closed -$221K – 380
2018
Q3
$221K Buy
+884
New +$215K 0.02% 359
2017
Q4
– Sell
-1,319
Closed -$205K – 439
2017
Q3
$205K Hold
1,319
– – 0.01% 415
2017
Q2
$213K Hold
1,319
– – 0.01% 392
2017
Q1
$204K Buy
+1,319
New +$182K 0.01% 377

Other funds holding IDXX

Lombard Odier Asset Management (Europe)'s IDXX Position: Q1 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 42,737 shares — an estimated $17.4M sold.

Lombard Odier Asset Management (Europe) first reported a position in IDXX in Q1 2017 and held it in 12 quarters. The position peaked at $17.4M in Q4 2022. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 42,737 Idexx Laboratories shares in Q1 2023, an estimated $17.4M.
  • Lombard Odier Asset Management (Europe) first reported a position in Idexx Laboratories in Q1 2017 and held it in 12 quarters.
  • Lombard Odier Asset Management (Europe)'s Idexx Laboratories position peaked at $17.4M in Q4 2022.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2023, filed 15 May 2023.